Provided by Tiger Trade Technology Pte. Ltd.

Amylyx Pharmaceuticals

33.64
+2.026.39%
Post-market: 33.690.0500+0.15%19:30 EDT
Volume:1.93M
Turnover:63.82M
Market Cap:4.22B
PE:-23.51
High:33.96
Open:31.84
Low:31.57
Close:31.62
52wk High:41.14
52wk Low:10.83
Shares:125.46M
Float Shares:109.51M
Volume Ratio:1.41
T/O Rate:1.76%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4309
EPS(LYR):-1.5305
ROE:-74.73%
ROA:-44.13%
PB:17.65
PE(LYR):-21.98

Loading ...

Amylyx up 17% after announcing expected results for Avexitide tomorrow

TIPRANKS
·
Aug 18

Amylyx to Release Phase 3 Lucidity Trial Topline Results for Avexitide in Post-Bariatric Hypoglycemia Aug. 18, 2026

Reuters
·
Aug 18

U.S. Research Roundup- Berkshire Hathaway, Exxon Mobil, Honeywell Technologies

Reuters
·
Aug 17

Toronto Stock Exchange Hits Record High as Oil Prices Rise

TIPRANKS
·
Aug 13

Is Amylyx (AMLX) Quietly Rewriting Its R&D Risk‑Reward Profile As Losses Deepen Without Revenue?

Simply Wall St.
·
Aug 10

Amylyx Pharmaceuticals (AMLX) Could Be 5% Undervalued After Second Quarter Earnings

Simply Wall St.
·
Aug 08

Emera Inc. CEO on board with plans to boost energy infrastructure in Maritimes

Bloomberg
·
Aug 07

Amylyx Pharmaceuticals Readies for Pivotal LUCIDITY Data

TIPRANKS
·
Aug 07

Amylyx Pharmaceuticals, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Earnings Flash (AMLX) Amylyx Pharmaceuticals Posts Q2 Loss $0.39 a Share, vs. FactSet Est of $0.35 Loss

MT Newswires Live
·
Aug 06

Amylyx Pharmaceuticals Q2 Posts Higher than Expected Loss

Reuters
·
Aug 06

Amylyx Q2 FY26 Net Loss Widens to $43.4 Million; SG&A Expenses Climb to $21.9 Million

Reuters
·
Aug 06

RAmylyx Pharma Q2 EPS $(0.39) Misses $(0.36) Estimate, Cash & Equivalents $279.8M. Cash runway Expected To Fund Operations Till 2028

Benzinga Earnings
·
Aug 06

Amylyx Pharmaceuticals Q2 EPS USD -0.39 Vs. IBES Estimate USD -0.36

Reuters
·
Aug 06

Amylyx Pharmaceuticals, - Cash Runway Expected to Fund Operations into 2028

THOMSON REUTERS
·
Aug 06

Press Release: Amylyx Pharmaceuticals Reports Second Quarter 2026 Financial Results

Dow Jones
·
Aug 06

Amylyx Pharmaceuticals Inc Expected to Post a Loss of 36 Cents a Share - Earnings Preview

Reuters
·
Aug 04

Press Release: Amylyx Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 6, 2026

Dow Jones
·
Aug 03

Amylyx Pharmaceuticals Schedules Quarterly Results Call

Reuters
·
Aug 03

Amylyx price target raised to $26 from $20 at Citi

TIPRANKS
·
Aug 03